Sanjay De Mel

机构：National University of Singapore, National University Cancer Institute, Singapore, National Cancer Centre Singapore, National University Health System · ORCID：0000-0002-8881-3537

发表论文 218 篇 · 总被引 1782 次 · h-index 23

代表论文

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003) (2025 · Blood Cancer Journal · 被引 2)
Targeting the CD47-SIRPalpha checkpoint in multiple myeloma (2025 · Discover Oncology · 被引 2)
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis (2026 · Journal of Clinical Oncology · 被引 1)
Monospecific and Bispecific Chimeric Antigen Receptor (CAR) T-cell Therapy in Multiple Myeloma: A Systematic Review, Meta-analysis and Meta-regression (2026 · Transplantation and Cellular Therapy · 被引 1)
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's Lymphoma (2025 · JCO Precision Oncology · 被引 1)
A phase 2 study of Daratumumab with Thalidomide and dexamethasone in relapsed and/or Refractory Myeloma (RRMM) (2025 · Blood Cancer Journal · 被引 1)